0001127602-20-028537.txt : 20201109
0001127602-20-028537.hdr.sgml : 20201109
20201109184015
ACCESSION NUMBER: 0001127602-20-028537
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201105
FILED AS OF DATE: 20201109
DATE AS OF CHANGE: 20201109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Flessner Kyle M
CENTRAL INDEX KEY: 0001751966
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03761
FILM NUMBER: 201299167
MAIL ADDRESS:
STREET 1: 12500 TI BOULEVARD
CITY: DALLAS
STATE: TX
ZIP: 75243
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TEXAS INSTRUMENTS INC
CENTRAL INDEX KEY: 0000097476
STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674]
IRS NUMBER: 750289970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: P.O. BOX 660199
CITY: DALLAS
STATE: TX
ZIP: 75266
BUSINESS PHONE: 9729953773
MAIL ADDRESS:
STREET 1: 12500 TI BLVD
STREET 2: PO BOX 660199
CITY: DALLAS
STATE: TX
ZIP: 75266
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-11-05
0000097476
TEXAS INSTRUMENTS INC
TXN
0001751966
Flessner Kyle M
12500 TI BOULEVARD
DALLAS
TX
75243
1
Sr. Vice President
Common Stock
2020-11-05
4
M
0
25000
52.93
A
78117
D
Common Stock
2020-11-05
4
S
0
25000
155.1445
D
53117
D
Common Stock
2020-11-09
4
M
0
24955
52.93
A
78072
D
Common Stock
2020-11-09
4
S
0
24955
161.6307
D
53117
D
NQ Stock Option (Right to Buy)
52.93
2020-11-05
4
M
0
25000
0
D
2026-01-29
Common Stock
25000
24955
D
NQ Stock Option (Right to Buy)
52.93
2020-11-09
4
M
0
24955
0
D
2026-01-29
Common Stock
24955
0
D
The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $155.0404 to $155.235. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $161.60 to $161.675. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
The option becomes exercisable in four equal annual installments beginning on January 29, 2017.
/s/ Katharine Kane, Attorney In Fact
2020-11-09